Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review
Authors
Keywords
-
Journal
Diagnostics
Volume 10, Issue 1, Pages 39
Publisher
MDPI AG
Online
2020-01-15
DOI
10.3390/diagnostics10010039
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Measurement of Urinary Level of a Specific Competing endogenous RNA network (FOS and RCAN mRNA/ miR-324-5p, miR-4738-3p, /lncRNA miR-497-HG) Enables Diagnosis of Bladder Cancer
- (2019) Sanaa Eissa et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- A phase III, randomized, open-label, multicenter, global study of durvalumab and bacillus calmette-guérin (BCG) versus BCG alone in high-risk, BCG-naïve non-muscle-invasive bladder cancer (NMIBC) patients (POTOMAC).
- (2019) Maria De Santis et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of miR-100 and miR-138 as prognostic biomarkers in non-muscle-invasive bladder cancer
- (2019) Ana Blanca et al. APMIS
- lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer
- (2019) Fuquan Jiang et al. BIOMEDICINE & PHARMACOTHERAPY
- Diagnostic predictive value of the Bladder EpiCheck test in the follow‐up of patients with non–muscle‐invasive bladder cancer
- (2019) Emanuela Trenti et al. CANCER CYTOPATHOLOGY
- Management of metastatic bladder cancer
- (2019) Rosa Nadal et al. CANCER TREATMENT REVIEWS
- lncRNA TUC338 is a potential diagnostic biomarker for bladder cancer
- (2019) Gang Li et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MiR-101 acts as a novel bio-marker in the diagnosis of bladder carcinoma
- (2019) Xiaoyan Chen MEDICINE
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
- (2019) Marko Babjuk et al. EUROPEAN UROLOGY
- Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology
- (2019) Maria Del Carmen Rodriguez Pena et al. VIRCHOWS ARCHIV
- Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study
- (2019) Rui Batista et al. Frontiers in Genetics
- Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients
- (2018) Judith Bosschieter et al. EUROPEAN UROLOGY
- Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non–Muscle-Invasive Bladder Cancer on Tumor Recurrence
- (2018) Edward M. Messing et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of Urinary DNA Methylation as a Marker for Recurrent Bladder Cancer: A 2-Center Prospective Study
- (2018) Tetsuya Shindo et al. UROLOGY
- An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
- (2018) Francesco Soria et al. WORLD JOURNAL OF UROLOGY
- Short-term benefit of smoking cessation along with glycopirronium on lung function and respiratory symptoms in mild COPD patients : a retrospective study
- (2018) Aldo Pezzuto et al. Journal of Breath Research
- Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
- (2018) Simeon U Springer et al. eLife
- Association of Cigarette, Cigar, and Pipe Use With Mortality Risk in the US Population
- (2018) Carol H. Christensen et al. JAMA Internal Medicine
- Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors
- (2018) Tuan Zea Tan et al. EUROPEAN UROLOGY
- Extracellular Vesicles in Bladder Cancer: Biomarkers and Beyond
- (2018) Yu-Ru Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer
- (2018) Ricardo Leão et al. INTERNATIONAL JOURNAL OF CANCER
- DNA hypermethylation within TERT promoter upregulates TERT expression in cancer
- (2018) Donghyun D. Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- Current Use and Promise of Urinary Markers for Urothelial Cancer
- (2018) William Tabayoyong et al. Current Urology Reports
- Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets
- (2017) Eugene J. Pietzak et al. EUROPEAN UROLOGY
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
- (2017) Marko Babjuk et al. EUROPEAN UROLOGY
- Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
- (2017) J. Alfred Witjes et al. EUROPEAN UROLOGY
- Validation of a mRNA-based urine test for bladder cancer detection in patients with hematuria
- (2017) F.J.P. Van Valenberg et al. EUROPEAN UROLOGY SUPPLEMENTS
- ILC2-modulated T cell–to-MDSC balance is associated with bladder cancer recurrence
- (2017) Mathieu F. Chevalier et al. JOURNAL OF CLINICAL INVESTIGATION
- Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications
- (2017) Stephanie A.M. Wankowicz et al. JOURNAL OF UROLOGY
- The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies
- (2017) Zheng Zhang et al. Oncotarget
- An integrated double-filtration microfluidic device for isolation, enrichment and quantification of urinary extracellular vesicles for detection of bladder cancer
- (2017) Li-Guo Liang et al. Scientific Reports
- Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications
- (2016) Boaz Kurtis et al. Annals of Diagnostic Pathology
- Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin
- (2016) Ashish M. Kamat et al. EUROPEAN UROLOGY
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours
- (2016) Peter A. Humphrey et al. EUROPEAN UROLOGY
- Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement
- (2016) Matthew I. Milowsky et al. JOURNAL OF CLINICAL ONCOLOGY
- Systemic, perioperative management of muscle-invasive bladder cancer and future horizons
- (2016) Samuel A. Funt et al. Nature Reviews Clinical Oncology
- Follow-up in non–muscle-invasive bladder cancer—International Bladder Cancer Network recommendations
- (2016) Wassim Kassouf et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non–muscle-invasive bladder cancer?—An International Bladder Cancer Network project
- (2016) Claudia Schmitz-Dräger et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- ImmunoCyt test compared to cytology in the diagnosis of bladder cancer: A meta-analysis
- (2016) HOUGUANG HE et al. Oncology Letters
- Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response
- (2015) Yogesh Kumar et al. BMC Medical Genomics
- Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature
- (2015) Luis A. Kluth et al. EUROPEAN UROLOGY
- Molecular Biology of Bladder Cancer
- (2015) William Martin-Doyle et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Mutations inTERTpromoter andFGFR3and telomere length in bladder cancer
- (2015) Ismail Hosen et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer
- (2015) Zhenqiang Fang et al. TUMOR BIOLOGY
- Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer
- (2015) Xin Zhang et al. Oncotarget
- Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up
- (2014) J. Bellmunt et al. ANNALS OF ONCOLOGY
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer
- (2014) Xiumei Jiang et al. INTERNATIONAL JOURNAL OF CANCER
- The Health Economics of Bladder Cancer: An Updated Review of the Published Literature
- (2014) Christina Yeung et al. PHARMACOECONOMICS
- Telomerase promoter mutations in cancer: an emerging molecular biomarker?
- (2014) João Vinagre et al. VIRCHOWS ARCHIV
- Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder
- (2013) E Xylinas et al. BRITISH JOURNAL OF CANCER
- Evaluation of urovysion and cytology for bladder cancer detection
- (2013) Haythem Dimashkieh et al. CANCER CYTOPATHOLOGY
- TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine
- (2013) I. Kinde et al. CANCER RESEARCH
- Maintenance Bacillus Calmette-Guérin Treatment of Non–muscle-invasive Bladder Cancer: A Critical Evaluation of the Evidence
- (2013) Behfar Ehdaie et al. EUROPEAN UROLOGY
- Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome
- (2013) Yves Allory et al. EUROPEAN UROLOGY
- Comprehensive Mutation Analysis of the TERT Promoter in Bladder Cancer and Detection of Mutations in Voided Urine
- (2013) Carolyn D. Hurst et al. EUROPEAN UROLOGY
- Conditional Survival After Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time
- (2013) Guillaume Ploussard et al. EUROPEAN UROLOGY
- TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism
- (2013) P. S. Rachakonda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Urine markers for detection and surveillance of bladder cancer
- (2013) Evanguelos Xylinas et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Epidemiology and Risk Factors of Urothelial Bladder Cancer
- (2012) Maximilian Burger et al. EUROPEAN UROLOGY
- A Multigene Urine Test for the Detection and Stratification of Bladder Cancer in Patients Presenting with Hematuria
- (2012) Paul O'Sullivan et al. JOURNAL OF UROLOGY
- Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity
- (2011) Ashish M. Kamat et al. BJU INTERNATIONAL
- Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic
- (2011) Christopher G.T. Blick et al. BJU INTERNATIONAL
- Markers Predicting Response to Bacillus Calmette-Guérin Immunotherapy in High-Risk Bladder Cancer Patients: A Systematic Review
- (2011) Tahlita C.M. Zuiverloon et al. EUROPEAN UROLOGY
- Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
- (2011) George J. Netto Nature Reviews Urology
- FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
- (2010) Lucie C. Kompier et al. PLoS One
- Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy
- (2009) Guru Sonpavde et al. CANCER
- An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer
- (2009) Per-Uno Malmström et al. EUROPEAN UROLOGY
- A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer
- (2009) Merle Hanke et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies
- (2008) Mika-P. Raitanen et al. WORLD JOURNAL OF UROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now